Current Affairs - National - Discussion

Discussion :: National - Latest Current Affairs (Q.No.2126)

2126. 

Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?

[A]. Employees' state Insurance Corporation
[B]. CSIR-Central Drug Research Institute
[C]. The Indian Council of Medical Research
[D]. All India Institute Of Medical Science

Answer: Option B

Explanation:

CSIR-Central Drug Research Institute Lucknow received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir. The Phase III Clinical Trials will be carried out at King George's Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS), and ERA's Lucknow Medical College & Hospital, Lucknow.

Post your comments here:

Name *:

Email   : (optional)

» Your comments will be displayed only after manual approval.